Prospects for therapeutic targeting of MicroRNAs in human immunological diseases

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5047-5052

  Luck, Marisa E ^a   Muljo, Stefan A ^b   Collins, Colm B ^a  

^a Children's Hospital Colorado   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; DICER; GAMMA INTERFERON; INTERLEUKIN 13; LENTIVIRUS VECTOR; MICRORNA; TRANSCRIPTION FACTOR FOXP3; MIRAVIRSEN; OLIGONUCLEOTIDE;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CROSS LINKING; CYTOKINE PRODUCTION; EXOSOME; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BINDING SITE; DRUG DELIVERY SYSTEM; GENETICS; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; INFLAMMATION; MOUSE;

ANIMALS; BINDING SITES; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; MICE; MICRORNAS; MOLECULAR TARGETED THERAPY; OLIGONUCLEOTIDES;

EID: 84929650326     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403146     Document Type: Review

References (42)

1. Lee, Y., C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, P. Provost, O. Radmark, S. Kim, and V. N. Kim. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
2. Hutvágner, G., J. McLachlan, A. E. Pasquinelli, E. Bálint, T. Tuschl, and P. D. Zamore. 2001. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
3. Olive, V., E. Sabio, M. J. Bennett, C. S. De Jong, A. Biton, J. C. McGann, S. K. Greaney, N. M. Sodir, A. Y. Zhou, A. Balakrishnan, et al. 2013. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. eLife 2: e00822. Available at: http://elifesciences.org/content/2/e00822.
4. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
5. Liu, J., M. A. Carmell, F. V. Rivas, C. G. Marsden, J. M. Thomson, J. J. Song, S. M. Hammond, L. Joshua-Tor, and G. J. Hannon. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441.
6. Song, J. J., S. K. Smith, G. J. Hannon, and L. Joshua-Tor. 2004. Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305: 1434-1437.
7. Yekta, S., I. H. Shih, and D. P. Bartel. 2004. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596.
8. Guo, H., N. T. Ingolia, J. S. Weissman, and D. P. Bartel. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
9. Bazzini, A. A., M. T. Lee, and A. J. Giraldez. 2012. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 336: 233-237.
10. Fukao, A., Y. Mishima, N. Takizawa, S. Oka, H. Imataka, J. Pelletier, N. Sonenberg, C. Thoma, and T. Fujiwara. 2014. MicroRNAs trigger dissociation of eIF4AI and eIF4AII from target mRNAs in humans. Mol. Cell 56: 79-89.
11. Fukaya, T., H. O. Iwakawa, and Y. Tomari. 2014. MicroRNAs block assembly of eIF4F translation initiation complex in Drosophila. Mol. Cell 56: 67-78.
12. Gebert, L. F., M. A. Rebhan, S. E. Crivelli, R. Denzler, M. Stoffel, and J. Hall. 2014. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 42: 609-621.
13. Elmén, J., M. Lindow, S. Schütz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjärn, H. F. Hansen, U. Berger, et al. 2008. LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899.
14. Cobb, B. S., T. B. Nesterova, E. Thompson, A. Hertweck, E. O'Connor, J. Godwin, C. B. Wilson, N. Brockdorff, A. G. Fisher, S. T. Smale, and M. Merkenschlager. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201: 1367-1373.
15. Cobb, B. S., A. Hertweck, J. Smith, E. O'Connor, D. Graf, T. Cook, S. T. Smale, S. Sakaguchi, F. J. Livesey, A. G. Fisher, and M. Merkenschlager. 2006. A role for Dicer in immune regulation. J. Exp. Med. 203: 2519-2527.
16. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
17. Liston, A., L.-F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky. 2008. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205: 1993-2004.
18. Zhang, N., and M. J. Bevan. 2010. Dicer controls CD8+ T-cell activation, migration, and survival. Proc. Natl. Acad. Sci. USA 107: 21629-21634.
19. Muljo, S. A., K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202: 261-269.
20. Hegazy, A. N., M. Peine, C. Helmstetter, I. Panse, A. Fröhlich, A. Bergthaler, L. Flatz, D. D. Pinschewer, A. Radbruch, and M. Löhning. 2010. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32: 116-128.
21. Koralov, S. B., S. A. Muljo, G. R. Galler, A. Krek, T. Chakraborty, C. Kanellopoulou, K. Jensen, B. S. Cobb, M. Merkenschlager, N. Rajewsky, and K. Rajewsky. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874.
22. Xu, S., K. Guo, Q. Zeng, J. Huo, and K.-P. Lam. 2012. The RNase III enzyme Dicer is essential for germinal center B-cell formation. Blood 119: 767-776.
23. Kuipers, H., F. M. Schnorfeil, H.-J. Fehling, H. Bartels, and T. Brocker. 2010. Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo. J. Immunol. 185: 400-409.
24. Oh, S. Y., S. Brandal, R. Kapur, Z. Zhu, and C. M. Takemoto. 2014. Global microRNA expression is essential for murine mast cell development in vivo. Exp. Hematol. 42: 919-923.e1. Available at: http://www.exphem.org/article/S0301-472X (14)00620-1/abstract. doi: 10.1016/j.exphem.2014.07.266
25. Chen, K., and N. Rajewsky. 2006. Natural selection on human microRNA binding sites inferred from SNP data. Nat. Genet. 38: 1452-1456.
26. Hafner, M., M. Landthaler, L. Burger, M. Khorshid, J. Hausser, P. Berninger, A. Rothballer, M. Ascano, Jr., A. C. Jungkamp, M. Munschauer, et al. 2010. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
27. Chi, S. W., J. B. Zang, A. Mele, and R. B. Darnell. 2009. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
28. Loeb, G. B., A. A. Khan, D. Canner, J. B. Hiatt, J. Shendure, R. B. Darnell, C. S. Leslie, and A. Y. Rudensky. 2012. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 48: 760-770.
29. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
30. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/ microRNA-155 for normal immune function. Science 316: 608-611.
31. Thai, T. H., H. C. Patterson, D. H. Pham, K. Kis-Toth, D. A. Kaminski, and G. C. Tsokos. 2013. Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse. Proc. Natl. Acad. Sci. USA 110: 20194-20199.
32. Escobar, T., C. R. Yu, S. A. Muljo, and C. E. Egwuagu. 2013. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 54: 4017-4025.
33. Murugaiyan, G., V. Beynon, A. Mittal, N. Joller, and H. L. Weiner. 2011. Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 187: 2213-2221.
34. O'Connell, R. M., D. Kahn, W. S. Gibson, J. L. Round, R. L. Scholz, A. A. Chaudhuri, M. E. Kahn, D. S. Rao, and D. Baltimore. 2010. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619.
35. Kurowska-Stolarska, M., S. Alivernini, L. E. Ballantine, D. L. Asquith, N. L. Millar, D. S. Gilchrist, J. Reilly, M. Ierna, A. R. Fraser, B. Stolarski, et al. 2011. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. USA 108: 11193-11198.
36. Blüml, S., M. Bonelli, B. Niederreiter, A. Puchner, G. Mayr, S. Hayer, M. I. Koenders, W. B. van den Berg, J. Smolen, and K. Redlich. 2011. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum. 63: 1281-1288.
37. Krützfeldt, J., N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with 'antagomirs.' Nature 438: 685-689.
38. Flierl, U., T. L. Nero, B. Lim, J. F. Arthur, Y. Yao, S. M. Jung, E. Gitz, A. Y. Pollitt, M. T. Zaldivia, M. Jandrot-Perrus, et al. 2015. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators. J. Exp. Med. 212: 129-137.
39. Collison, A., J. Mattes, M. Plank, and P. S. Foster. 2011. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 128: 160-167.e4. Available at: http://www.jacionline.org/article/S0091-6749(11)00578-1/fulltext.
40. Mattes, J., A. Collison, M. Plank, S. Phipps, and P. S. Foster. 2009. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc. Natl. Acad. Sci. USA 106: 18704-18709.
41. Sharma, A., M. Kumar, T. Ahmad, U. Mabalirajan, J. Aich, A. Agrawal, and B. Ghosh. 2012. Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model. J. Appl. Physiol. 113: 459-464.
42. Kumar, M., T. Ahmad, A. Sharma, U. Mabalirajan, A. Kulshreshtha, A. Agrawal, and B. Ghosh. 2011. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J. Allergy Clin. Immunol. 128: 1077-1085.e10. Available at: http://www.jacionline.org/article/S0091-6749(11)00672-5/fulltext.